NCT03936335Completed
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
Dupilumab and Pregnancy Outcomes: A Retrospective Cohort Study Using Administrative Healthcare Databases (Dupi PODS)
Source: ClinicalTrials.gov · Last updated 28 Sept 2026
Brief summary (registry, in English)
The objective of this study is to describe and compare the incidence of adverse pregnancy outcomes (spontaneous abortion/miscarriage, stillbirth) and prevalence of adverse infant outcomes (major congenital malformations \[MCMs\], small for gestational age \[SGA\]) in women with AD who are treated with dupilumab during pregnancy relative to women with AD who are not treated with dupilumab during pregnancy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 12343 (actual)
- First submitted
- 30 Apr 2019
- Start date
- 30 Sept 2019
- Primary completion date
- 13 Apr 2026
- Lead sponsor
- Regeneron Pharmaceuticals
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT03936335
What you commit to
- Study type: Observational
- Participants enrolled: 12343
- From 30 Sept 2019 to the primary completion date, 13 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Continuous medical and pharmacy benefit coverage for at minimum 6 months prior to and including the estimated LMP
- Diagnosis code indicative of AD in the period from up to 1 year prior to the estimated LMP through the end of the pregnancy
- Note: Other Protocol Defined Inclusion / Exclusion Criteria Apply
Age in the registry: 18 years to 49 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.